Skip to main content
SpringerLink
Log in

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

This study was carried out to examine some components of in vivo immune function in major depression and schizophrenia. Toward this end, plasma concentrations of interleukin-1β (IL-1β) and IL-6, soluble IL-2 receptor (sIL-2R), and transferrin receptor (TfR) were measured in 28 normal controls, 11 schizophrenics and 13 major-depressed patients. Schizophrenic and major-depressed patients showed significantly higher plasma sIL-2R and TfR than normal controls. There was a trend toward higher plasma IL-6 in the psychiatric patients, and particularly in schizophrenic patients, than in normal volunteers. In normal controls and in the total study group, there were highly significant and positive correlations between plasma TfR and sIL-2R concentrations. It is suggested that schizophrenia and major depression are characterized by immune disorders that may indicate activation of cell-mediated immunity such as T-cell activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), 3rd edn, revised. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Beguin Y (1992) The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis. Haematol 77:1–10

    Google Scholar 

  • Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S, Krupp NE (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17:41–47

    Google Scholar 

  • Caruso C, Candore G, Cigna D, Colucci AT, Modica MA (1993) Biological significance of soluble II-2 receptor. Med Inflamm 2: 3–21

    Google Scholar 

  • Charles G, Machowski R, Brohee D, Wilmotte J, Kennes B (1992) Lymphocyte subsets in major depressive patients. Neuropsychobiology 25:94–98

    Google Scholar 

  • Deberdt R, Van Hooren J, Biesbrouk M, Amery W (1976) Antinuclear factor positive in mental depression: a single disease entity? Biol Psychiatry 11:69–74

    Google Scholar 

  • De Groote D, Zangerle PF, Gevaert Y, Fasotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P (1992) Direct stimulation of cytokines in whole blood. Comparison with isolated PBMC stimulation. Cytokine 4:239–248

    Google Scholar 

  • de Jong G, van Dijk JP, van Eijk HG (1990) The biology of transferrin. Clin Chim Acta 190:1–46

    Google Scholar 

  • DeLisi LE (1987) Viral and immune hypotheses for schizophrenia. In: Meltzer HY (ed) Psychopharmacology, the third generation of progress. Raven Press, New York, pp 765–771

    Google Scholar 

  • DeLisi LE, Goodman S, Neckers LM, Wyatt RJ (1982) An analysis of lymphocyte subpopulations in schizophrenic patients. Biol Psychiatry 17:1003–1009

    Google Scholar 

  • DeLisi LE, Weber RJ, Pert CB (1985) Are there antibodies against brain in sera from schizophrenic patients? Biol Psychiatry 20: 94–119

    Google Scholar 

  • Dunbar PR, Hill J, Neale TJ, Mellsop GW (1992) Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med 22:1051–1057

    Google Scholar 

  • Endicott J, Spitzer RL (1976) A diagnostic interview; the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 835:837–844

    Google Scholar 

  • Ganguli R, Rabin BS (1989) Increased serum interleukin-2 receptor concentration in schizophrenic and brain-damaged subjects. Arch Gen Psychiatry 46:292

    Google Scholar 

  • Ganguli R, Rabin BS, Belle SH (1989) Decreased interleukin-2 production in schizophrenic patients. Biol. Psychiatry 26:427–430

    Google Scholar 

  • Ganguli R, Brar JS, Solomon W, Chengappa KNR, Rabin BS (1992) Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiatry Res 44:113–123

    Google Scholar 

  • Gastpar M, Muller W (1981) Autoantibodies in affective disorders. Progr Neuropsychopharmacol Biol Psychiatry 5:91–96

    Google Scholar 

  • Heath RG, Krupp IM (1967) Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gen Psychiatry 16:1–9

    Google Scholar 

  • Henneberg A, Riedl B, Dumke H-O, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatr Neurol Sci 239:283–284

    Google Scholar 

  • Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR (1992) Elevated levels of acute-phase plasma proteins in major depression. Biol Psychiatry 32:1035–1041

    Google Scholar 

  • Keyna U, Nusslein I, Rohwer P, Kalden JR, Manger B (1991) The role of the transferrin receptor for the activation of human lymphocytes. Cell Immunol 132:411–422

    Google Scholar 

  • Licinio J, Krystal JH, Seibyl JP, Altemus M, Charney DS (1991) Elevated central levels of interleukin-2 in drug-free schizophrenic patients. Schizophr Res 44:372

    Google Scholar 

  • Maes M (1993) A review on the acute-phase response in major depression. Rev Neurosci 4:407–416

    Google Scholar 

  • Maes M (1995) The Interleukin hypothesis of major depression. Progr Psychopharmacol Biol Psychiatry (in press)

  • Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Minner B, Raus J (1991a) Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin-1β, and soluble interleukin-2-receptor production. Acta Psychiatry Scand 84:379–386

    Google Scholar 

  • Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Raus J (1991b) Antiphospholipid, anti-nuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J Affect Disord 21:133–140

    Google Scholar 

  • Maes M, Scharpé S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute-phase proteins and HPA-axis function in severe depression. Psychiatry Res 49:11–27

    Google Scholar 

  • Maes M, Smith R, Scharpé S (1995) The monocyte-T lymphocyte hypothesis of major depression. Psychoneuroendocrinology (invited editorial; in press)

  • McAllister CG, Rapaport MH, Pickar D, Paul SM (1991) Autoimmunity and schizophrenia. In: Tamminga CA, Schulz SC (eds) Advances in Neuropsychiatry and psychopharmacology, volume I: schizophrenia research. Raven Press, New York, pp 111–118

    Google Scholar 

  • Muller N, Ackenheil M, Hofschuster E (1989) Altered T-cell number and reduced suppressor cell activity in patients with affective psychosis. In: Hadden JW, Masek K, Nistico G (eds) Interaction among central nervous system, neuroendocrine and immune systems. Pythagora Press, Rome, pp 385–394

    Google Scholar 

  • Muller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1991) Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res 37:147–160

    Google Scholar 

  • Muller N, Hofschuster E, Ackenheil M, Eckstein R (1993) T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr Scand 87:66–71

    Google Scholar 

  • Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM (1989) Elevated levels of soluble interleukin-2 receptors in schizophrenia. Arch Gen Psychiatry 46:291–292

    Google Scholar 

  • Skikne BS, Flowers CH, Cook JD (1990) Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75: 1870–1986

    Google Scholar 

  • Sluzewska A, Rybakowski J, Sobieska M, Wiktorowicz K (1994) Concentration and microheterogeneity glycophorms of ±1-acid lycoprotein in major depressive disorder. J Affect Disord (in press)

  • Smidt E, Axelsson R, Steen G (1988) Treatment of chronic schizophrenia with glucocorticoids in combination with neuroleptic drugs: a pilot study. Curr Ther Res 43:842–850

    Google Scholar 

  • Smith RS (1991a) The macrophage theory of depression. Med Hypotheses 35:298–306

    Google Scholar 

  • Smith RS (1991b) Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Med Hypotheses 34:225–229

    Google Scholar 

  • Smith RS (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 39:248–257

    Google Scholar 

  • Song C, Dinan T, Leonard BE (1994) Changes in immunoglobulin, complement and acute-phase protein levels in the depressed patients and normal controls. J Affect Disord 30:283–288

    Google Scholar 

  • Tondo L, Pani PP, Pellegrini-Bettoli R, Milia G, Manconi PE (1988) T-lymphocytes in depressive disorder. Med Sci Res 16: 867–868

    Google Scholar 

  • Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H, Zarifian E, Bach JF (1989) Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry 46:609–616

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. AZ Stuivenberg, University Department of Psychiatry, 267 Lange Beeldekenstraat, 2060, Antwerp, Belgium

    M. Maes, H. Y. Meltzer & P. Buckley

  2. Eurogenetics, Tessenderlo, Belgium

    E. Bosmans

Authors
  1. M. Maes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Y. Meltzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Bosmans
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maes, M., Meltzer, H.Y., Buckley, P. et al. Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression. Eur Arch Psychiatry Clin Nuerosci 244, 325–329 (1995). https://doi.org/10.1007/BF02190412

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02190412

Key words

Search

Navigation